Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › GRP-R agonistic 177-lutetium-labeled bombesin derivatives for diagnosis and treatment of prostate cancer

GRP-R agonistic 177-lutetium-labeled bombesin derivatives for diagnosis and treatment of prostate cancer

US Patent 9827338 · Granted Nov 28, 2017

Estimated economic value: $3,571,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Diamine compound, polyimide precursor and polyimide film using the same, and use2025
Display device and method of manufacturing light-emitting element2025
Composition for improving respiratory diseases using Lactobacillus plantarum str2025
Display device and method of fabricating the same2025
Catalyst for electrochemical synthesis of ammonia, method for preparing same, an2025
Catalyst for fuel cell, fuel cell comprising the same and preparation method of 2025
Apparatus and method for establishing IR control code database of user terminal2025
Display device and method for manufacturing thereof2025
System and module for automatically washing and sterilizing heat exchanger of sy2025
Deuterium-containing compound, and organic light-emitting device comprising same2025
Polybenzimidazole-based electrolyte membrane for alkaline water electrolysis and2025
Apparatus and method for estimating body temperature2025